Home › Funds › RA CAPITAL MANAGEMENT, L.P. › BCAX
RA CAPITAL MANAGEMENT, L.P. position in BCAX
BICARA THERAPEUTICS INC · Health Care
RA CAPITAL MANAGEMENT, L.P. reported holding 7,255,993 shares of BCAX (BICARA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$135.0M, representing 1.39% of its reported portfolio and ranking #16 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How RA CAPITAL MANAGEMENT, L.P.'s BCAX position evolved
RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in BCAX in Q3 2024 at 6,955,993 shares (US$177.2M). The position peaked in Q2 2026 at 7,255,993 shares, worth US$215.4M. Across 9 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 7,255,993 shares valued at US$135.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 6.96M | $177.17M | New |
| Q4 2024 | 6.96M | $121.17M | Hold |
| Q1 2025 | 6.96M | $90.64M | Hold |
| Q2 2025 | 6.96M | $64.62M | Hold |
| Q3 2025 | 6.96M | $109.84M | Hold |
| Q4 2025 | 6.96M | $117.07M | Hold |
| Q1 2026 | 7.26M | $144.32M | Add |
| Q2 2026 | 7.26M | $215.43M | Hold |
| Q3 2026 | 7.26M | $135.03M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCAX and 13F data
BCAX (BICARA THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in BCAX — the largest reported positions include Vestal Point Capital, LP (US$102.8M), Siren, L.L.C. (US$102.4M), Deep Track Capital, LP (US$76.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCAX
- Vestal Point Capital, LP 5.53M sh · $102.82M · Q3 2026
- Siren, L.L.C. 5.50M sh · $102.41M · Q3 2026
- Deep Track Capital, LP 4.10M sh · $76.30M · Q3 2026
- TPG GP A, LLC 3.01M sh · $56.02M · Q3 2026
- Red Tree Management, LLC 2.92M sh · $54.35M · Q3 2026
- Omega Fund Management, LLC 1.76M sh · $32.75M · Q3 2026
- Jones Hill Capital LP 1.06M sh · $19.81M · Q3 2026
- Palo Alto Investors LP 689.34K sh · $12.83M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 668.38K sh · $12.44M · Q3 2026
- Aisling Capital Management LP 548.92K sh · $10.22M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 427.88K sh · $7.96M · Q3 2026
- DAFNA Capital Management LLC 299.95K sh · $5.58M · Q3 2026
More on RA CAPITAL MANAGEMENT, L.P.
FAQ
How long has RA CAPITAL MANAGEMENT, L.P. held BCAX?
RA CAPITAL MANAGEMENT, L.P. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is RA CAPITAL MANAGEMENT, L.P.'s current position in BCAX?
As of Q3 2026, RA CAPITAL MANAGEMENT, L.P. holds 7.26M shares of BCAX (BICARA THERAPEUTICS INC), valued at $135.03M, representing 1.39% of its reported portfolio and ranking #16.
Has RA CAPITAL MANAGEMENT, L.P. been buying or selling BCAX?
In the latest 13F filing (Q3 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in BCAX. The position peaked in Q2 2026 at 7.26M shares.
Which other funds hold BCAX?
Other major institutional holders of BCAX include Vestal Point Capital, LP, Siren, L.L.C., Deep Track Capital, LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.